Chromition
Develops fluorescent detection technologies and diagnostic systems for cancer and genomic testing
Highlights
- New on EvolcAdded 2026-11-16
About Chromition
Chromition develops Luminspheres fluorescent technology and diagnostic systems for immunofluorescence, cancer screening from liquid biopsies, HER2 detection in breast cancer tissue, and CRISPR-based genomic testing.
Its products support researchers and diagnostic use, including detection and analysis of biological targets, circulating tumour cells, HER2 levels, and target RNA. Digital analysis software supports cancer screening and treatment selection.
The company was founded in 2014 and invented at the University of Manchester. Its registered headquarters are in Manchester, United Kingdom.
Product: Luminspheres fluorescent technology and diagnostic systems for immunofluorescence, liquid-biopsy cancer screening, HER2 detection, and CRISPR testing.
Jobs at Chromition
More biotech & pharma companies
Chugai Pharma Europe
European pharmaceutical operations and product support for patients and medical communities across the regionCiteab
Provides citation-based reagent search and life science data services for researchers and life science suppliersNew on EvolcCizzle Biotechnology
Non-invasive blood test for early lung cancer detection based on the CIZ1B biomarker, aimed at healthcare providers and patientsClinicmeta
UK clinical trial liaison, study management and disclosure services for international pharma and device sponsorsNew on EvolcClydesdale Pharma
Generic medicines manufacturing, testing and distribution for UK pharmacies, hospitals and pharmaceutical partnersNew on EvolcCNX Therapeutics
Licenses and distributes specialty medicines for CNS and critical care conditions in 60+ markets
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.